Drug
Follitropin Alfa Lutropin Alfa
Follitropin Alfa Lutropin Alfa: highest development phase Phase 3, developed by Merck. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Merck
Trials
| Drug | Phase | Indication |
|---|---|---|
| Follitropin alfa/lutropin alfa (MBJ-0011) NCT07340827 | Phase 3 | Infertility |
Latest
No recent events.
Follow Follitropin Alfa Lutropin Alfa on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.